相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A suite of DNA methylation markers that can detect most common human cancers
Lukas Vrba et al.
EPIGENETICS (2018)
The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review
Judith Bosschieter et al.
EPIGENOMICS (2018)
MAL and TMEM220 are novel DNA methylation markers in human gastric cancer
Boram Choi et al.
BIOMARKERS (2017)
DNA Methylation-Based Biomarkers
Leandro Cerchietti et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2017)
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
Willemien Beukers et al.
JOURNAL OF UROLOGY (2017)
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
Jorge Torres-Ferreira et al.
MOLECULAR CANCER (2017)
Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers
Jie Zhang et al.
BMC GENOMICS (2017)
Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer
Wina Verlaat et al.
CLINICAL CANCER RESEARCH (2017)
MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma
Nuno Andre Padrao et al.
BRITISH JOURNAL OF CANCER (2017)
Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer
Mark O. Kitchen et al.
EPIGENETICS (2016)
Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN
M. H. Uijterwaal et al.
GYNECOLOGIC ONCOLOGY (2016)
Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence
Saskia M. Wilting et al.
ONCOTARGET (2016)
Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer
Alexandra Kalmar et al.
BMC CANCER (2015)
DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach
A. J. Hubers et al.
BRITISH JOURNAL OF CANCER (2015)
GHSR hypermethylation: a promising pan-cancer marker
Pouria Jandaghi et al.
CELL CYCLE (2015)
GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers
Evgeny A. Moskalev et al.
ONCOTARGET (2015)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer
Lise M. A. De Strooper et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
Raju Kandimalla et al.
CLINICAL CANCER RESEARCH (2013)
Methylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer
Takashi Shimizu et al.
EUROPEAN UROLOGY (2013)
Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis
Renske D. M. Steenbergen et al.
JOURNAL OF PATHOLOGY (2013)
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Thomas Reinert et al.
CLINICAL CANCER RESEARCH (2011)
Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events
Reza R. Serizawa et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
Bruce J. Schlomer et al.
JOURNAL OF UROLOGY (2010)
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis
Renee M. Overmeer et al.
JOURNAL OF PATHOLOGY (2009)
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
T. E. Buffart et al.
BRITISH JOURNAL OF CANCER (2008)
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder
Yair Lotan et al.
JOURNAL OF UROLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Guidelines for development of diagnostic markers in bladder cancer
Peter J. Goebell et al.
WORLD JOURNAL OF UROLOGY (2008)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis
MP Raitanen et al.
EUROPEAN UROLOGY (2002)
分享论文
